Nasdaq
$2.80▲ 0.18%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $219.9MShares out 78.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
16- 10.13Regular26.10.14 02:37SCHEDULE 13GOwnership#●●●#●●●
Lexeo Therapeutics, Inc.
JPMorgan Chase & Co. has filed a SCHEDULE 13G regarding its beneficial ownership in Lexeo Therapeutics, Inc. This filing serves to formally disclose the investor's stake in the company.…more
$2.80+0.18%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.29After-hours26.09.30 05:208-KKey event
Lexeo Therapeutics, Inc.
Lexeo Therapeutics completed its acquisition of Mantle Therapeutics on September 29, 2026. The transaction involved an upfront payment of $5.3 million in cash and $3 million in common stock, with additional contingent milestone payments of up to $13 million.…more
$2.80+0.18%vs prev closeView filingShare - 9.28After-hours26.09.29 06:154Ownership
Lexeo Therapeutics, Inc.
Insider Louis Edward Tamayo of Lexeo Therapeutics, Inc. reported a change in beneficial ownership of securities effective September 24, 2026. This filing serves as the official disclosure of the insider's equity transaction.…more
$2.80+0.18%vs prev closeView filingShare
15 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 6d agoPre-market26.10.19 20:00#●●●#●●●
Lexeo Therapeutics to Host Investor Educational Event on PKP2-ACM Clinical Endpoints…more
Lexeo Therapeutics will host an educational event for investors focusing on clinical endpoints and outcome measures for PKP2-ACM. The event features expert discussions on disease assessment, but does not involve new clinical data or financial results.…more
$2.80+0.18%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.8Pre-market26.10.08 20:00
●●●●●●●● ●●●●● ●●●●●●
Lexeo Therapeutics announced its participation in a fireside chat at the 10th Annual Chardan Healthcare Conference on October 20, 2026. The session will be available via live webcast on the company's investor relations website.…more
$2.80+0.18%vs prev close - 10.1Pre-market26.10.01 22:00
●●●●●●●● ●●●●● ●●●●●●
Lexeo Therapeutics will deliver an oral presentation on its gene therapy candidate LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026. The presentation will highlight new analyses of neurologic outcomes alongside previously reported cardiac benefits.…more
$2.80+0.18%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report